StockData
Clene Inc. logo

Clene Inc. (CLNN) stock

CLNNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$3.22−0.44 (-12.02%)

Close on Nov 17, 2026Market cap $41.37MP/E –Yield –

Clene pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Clene's pe ratio was 6.1× on Feb 28, 2023.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Feb 28, 20236.1×+2.0
2022Dec 30, 20224.1×–

More Clene figures

See a number that looks wrong?